PeptideStack
5.2kquestions
20kanswers
220users

What is the dead-space loss per draw with a 29G needle at 1 mg/mL?

Asked 28 Aug 2024Modified 20 months agoViewed 39k times
39

The particulars: a 29G needle · 1 mg/mL.

I would rather understand the derivation than memorise the outcome.

Two people I asked gave two answers that differ by a factor of ten, which is suggestive.

Can someone walk through the arithmetic step by step?

dead-space
dead-space

The volume trapped in the syringe hub and needle after the plunger bottoms out. It is small in absolute terms and large as a fraction of a small…

110 questions
insulin-syringe
insulin-syringe

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit…

268 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
SS
askedswirl_dont_shake19k2828 Aug 2024

2 Answers

Accepted answer first, then by votes
77

Accepted answer

Mechanically, dead space is the volume trapped in the syringe hub and needle after the plunger bottoms out, and it is the reason your 10 mg vial yields only 9.5 mg of usable draws.

The needle lumen volume is under a microlitre in a typical fine-gauge configuration, so the needle is not the problem.

Reading a lyophilised cake

AppearanceInterpretationAction
Intact opaque puck, proud of baseCycle ran correctlyProceed
Slumped to one sideShipped before fully dry, or vibrationUsually usable; note it
Glassy translucent filmCollapse above glass transitionTest before use
Melt-back ring at stopperThermal excursion in transitTest before use
No visible cake at allVery low fill, or nothing thereWeigh it; query the supplier

To be exact about it, at 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.

Published inter-laboratory comparisons of dead-space measurements on identical syringes show good agreement, suggesting the numbers are reliable.

Buy the right syringe — a fixed-needle insulin syringe is cheap and solves the problem.

edited 15 Nov 2024 by sian_llewellyn — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
SL
answered · acceptedsian_llewellyn85k24819 Oct 2024
Two of us worked through this independently and arrived here, so it is at least reproducible. – esther_vandeVelde 9 months ago
2Worth adding that the method section is where the answer usually is. – ines_brandt 14 days ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
-1

The switch to a low-dead-space syringe nearly doubles your usable vial, which is better than switching suppliers if you are looking for cost savings.

Be sceptical of anything advertised as low dead space that retains a conventional plunger tip: if you can look into the fitting with the plunger fully forward and see an open conical void, that void is your dead space.

Mechanically, delivered peptide = 10 x 0.5 mg = 5.0 mg. Lost to dead space = 10 x 84 µL = 840 µL x 0.005 = 4.2 mg. Yield = 50 per cent.

The World Health Organisation guidance on injection equipment adopted the same high-versus-low dead-space distinction, using a low-dead-space threshold in the low single-digit microlitres.

The switch nearly doubles your vial, which is better than most other optimisations combined.

edited 15 Nov 2024 by marcus_thorbjorn — added the placebo-arm figures

shareimprove this answerflag
MT
answeredmarcus_thorbjorn16k2830 Oct 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.